Structure Therapeutics Inc. (GPCR) analyst actions
Rating and price-target actions on GPCR in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the GPCR overview →
1 measured GPCR analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity | Press release | +0.33% | -2.49% |
Keep exploring
More GPCR: earnings → · SEC filings → · GPCR overview →